Mineralys Therapeutics, Inc. (MLYS) Deep Dive Video
Summary
Mineralys is a cash-rich, single-asset bet on lorundrostat—an FDA decision and the eventual label will determine whether it becomes a cardiorenal standard of care or a niche specialist drug.